Using this monoclonal antibody, we also demonstrated that CCL21 is expressed in the mucosal venule endothelium of the majority of inflammatory bowel diseases, including Crohn’s disease, ulcerative colitis, and celiac disease. Here, CCL21 is linked to inflammatory bowel disease.